반응식
[CH2:1]([S:8][CH2:9][C@@H:10]([C:12]([OH:14])=O)[NH2:11])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[OH-].[Na+].[C:17]1([N:23]=[C:24]=[S:25])[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1>>[C:17]1([N:23]2[C:12](=[O:14])[CH:10]([CH2:9][S:8][CH2:1][C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=3)[NH:11][C:24]2=[S:25])[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1참가 물질
4
실험 절차
When approximately equimolar amounts of S-benzylcysteine, sodium hydroxide, and phenylisothiocyanate was reacted according to the procedure described for the preparation of the compound of Example 2, the title compound herein was obtained.
출처 및 근거
- ORD 기록
- ord-cb4adb0fc1354ee7b5563db546de0263
- 출처 데이터셋
- uspto-grants-1992_08
- 특허 번호
- US05137904
연결된 노트
불러오는 중…